frcp

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand EczemaPeerVoice Endocrinology & Metabolic Disorders Audio23:38Notes
   +Listen later
2. 2▶Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand EczemaPeerVoice Endocrinology & Metabolic Disorders Video23:38Notes
   +Watch later
3. 3▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Clinical Pharmacology Audio19:20Notes
   +Listen later
4. 4▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Clinical Pharmacology Audio32:12Notes
   +Listen later
5. 5▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Clinical Pharmacology Video19:20Notes
   +Watch later
6. 6▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Clinical Pharmacology Video32:12Notes
   +Watch later
7. 7▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Clinical Pharmacology Audio26:33Notes
   +Listen later
8. 8▶John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant CommunityPeerVoice Clinical Pharmacology Audio17:39Notes
   +Listen later
9. 9▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Clinical Pharmacology Audio16:39Notes
   +Listen later
10. 10▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Clinical Pharmacology Video26:33Notes
    +Watch later
11. 11▶John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant CommunityPeerVoice Clinical Pharmacology Video17:39Notes
    +Watch later
12. 12▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Clinical Pharmacology Video16:39Notes
    +Watch later
13. 13▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Audio16:39Notes
    +Listen later
14. 14▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Video16:39Notes
    +Watch later
15. 15▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Endocrinology & Metabolic Disorders Audio1:17:14Notes
    +Listen later
16. 16▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Endocrinology & Metabolic Disorders Video1:17:14Notes
    +Watch later
17. 17▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Clinical Pharmacology Audio1:17:14Notes
    +Listen later
18. 18▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Clinical Pharmacology Video1:17:14Notes
    +Watch later
19. 19▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Audio1:17:14Notes
    +Listen later
20. 20▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Video1:17:14Notes
    +Watch later
21. 21▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Endocrinology & Metabolic Disorders Audio25:41Notes
    +Listen later
22. 22▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Endocrinology & Metabolic Disorders Video25:41Notes
    +Watch later
23. 23▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Clinical Pharmacology Audio25:41Notes
    +Listen later
24. 24▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Clinical Pharmacology Video25:41Notes
    +Watch later
25. 25▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Immunology & Infectious Disease Audio20:43Notes
    +Listen later
26. 26▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Clinical Pharmacology Audio20:43Notes
    +Listen later
27. 27▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Clinical Pharmacology Audio18:45Notes
    +Listen later
28. 28▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Clinical Pharmacology Audio19:41Notes
    +Listen later
29. 29▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Clinical Pharmacology Video20:43Notes
    +Watch later
30. 30▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Clinical Pharmacology Video18:45Notes
    +Watch later
31. 31▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Clinical Pharmacology Video19:41Notes
    +Watch later
32. 32▶Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday PracticePeerVoice Endocrinology & Metabolic Disorders Audio35:42Notes
    +Listen later
33. 33▶Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday PracticePeerVoice Endocrinology & Metabolic Disorders Video35:42Notes
    +Watch later
34. 34▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Audio1:20:09Notes
    +Listen later
35. 35▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Video1:20:09Notes
    +Watch later
36. 36▶Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 DiabetesPeerVoice Endocrinology & Metabolic Disorders Audio1:19:25Notes
    +Listen later
37. 37▶Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We CanPeerVoice Endocrinology & Metabolic Disorders Audio20:02Notes
    +Listen later
38. 38▶Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 DiabetesPeerVoice Endocrinology & Metabolic Disorders Video1:19:25Notes
    +Watch later
39. 39▶Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We CanPeerVoice Endocrinology & Metabolic Disorders Video20:02Notes
    +Watch later
40. 40▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Audio36:53Notes
    +Listen later
41. 41▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Video36:53Notes
    +Watch later
42. 42▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Audio40:01Notes
    +Listen later
43. 43▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Video40:01Notes
    +Watch later
44. 44▶Louise Moist, MD, MSc, CCPE / Peter J. Lin, MD, CCFP - Managing CKD With SGLT2 Inhibitors in Primary Care: Applying New Evidence Into Clinical PracticePeerVoice Endocrinology & Metabolic Disorders Video14:00Notes
    +Watch later
45. 45▶Louise Moist, MD, MSc, CCPE / Peter J. Lin, MD, CCFP - Managing CKD With SGLT2 Inhibitors in Primary Care: Applying New Evidence Into Clinical PracticePeerVoice Heart & Lung Video14:00Notes
    +Watch later
46. 46▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Immunology & Infectious Disease Audio21:52Notes
    +Listen later
47. 47▶Yohei Doi, MD, PhD - Know the Risk, Act on Evidence: Strategic Interventions in COVID-19 Care of High-Risk PatientsPeerVoice Immunology & Infectious Disease Audio28:36Notes
    +Listen later
48. 48▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Endocrinology & Metabolic Disorders Audio21:52Notes
    +Listen later
49. 49▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Endocrinology & Metabolic Disorders Video21:51Notes
    +Watch later
50. 50▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Heart & Lung Audio21:52Notes
    +Listen later